Log in

Psychemedics Stock Forecast, Price & News

+0.03 (+0.70 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $4.31
50-Day Range
MA: $4.46
52-Week Range
Now: $4.31
Volume6,247 shs
Average Volume23,930 shs
Market Capitalization$23.83 million
P/E RatioN/A
Dividend YieldN/A
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, synthetic cannabinoids, and benzodiazepines, as well as opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations, as well as school and government entities. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.80 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Current SymbolNASDAQ:PMD



Sales & Book Value

Annual Sales$37.68 million
Cash Flow$0.98 per share
Book Value$3.05 per share


Net Income$1.54 million


Market Cap$23.83 million
Next Earnings Date10/27/2020 (Estimated)
OptionableNot Optionable
+0.03 (+0.70 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

How has Psychemedics' stock price been impacted by COVID-19 (Coronavirus)?

Psychemedics' stock was trading at $6.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PMD stock has decreased by 38.0% and is now trading at $4.31.
View which stocks have been most impacted by COVID-19

When is Psychemedics' next earnings date?

Psychemedics is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for Psychemedics

How were Psychemedics' earnings last quarter?

Psychemedics Corp. (NASDAQ:PMD) posted its earnings results on Wednesday, August, 12th. The company reported ($0.37) earnings per share (EPS) for the quarter. The business earned $3.31 million during the quarter. Psychemedics had a negative net margin of 7.01% and a negative return on equity of 7.31%.
View Psychemedics' earnings history

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics declared a quarterly dividend on Tuesday, February 11th. Investors of record on Friday, February 21st will be paid a dividend of $0.18 per share on Tuesday, March 3rd. This represents a $0.72 dividend on an annualized basis and a yield of 16.71%. The ex-dividend date is Thursday, February 20th.
View Psychemedics' dividend history

Who are some of Psychemedics' key competitors?

What other stocks do shareholders of Psychemedics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Canopy Growth (CGC), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG).

Who are Psychemedics' key executives?

Psychemedics' management team includes the following people:
  • Mr. Raymond C. Kubacki Jr., Chairman, CEO & Pres (Age 74)
  • Mr. Neil Lerner, VP of Fin. & Treasurer (Age 51)
  • Dr. Michael I. Schaffer, VP of Laboratory Operations (Age 74)
  • Dr. Werner A. Baumgartner Ph.D., Founder
  • Ms. Annette Baumgartner, Founder

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How do I buy shares of Psychemedics?

Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $4.31.

How big of a company is Psychemedics?

Psychemedics has a market capitalization of $23.83 million and generates $37.68 million in revenue each year. Psychemedics employs 250 workers across the globe.

What is Psychemedics' official website?

The official website for Psychemedics is www.psychemedics.com.

How can I contact Psychemedics?

Psychemedics' mailing address is 289 GREAT ROAD Suite 200, ACTON MA, 01720. The company can be reached via phone at 978-206-8220.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.